Agenda

A question and answer period will follow each presentation. A minimum of 25% of each presentation will be allowed for Q & A.

7:30 Registration and Networking Breakfast
8:00 Welcome and Introductions
Dr. Christine Chen
8:10 Overview: Efficacy of standard of care CAR T:

8:10 Aggressive lymphoma
Dr. John Kuruvilla (Princess Margaret)
8:30 Acute lymphoblastic leukemia (ALL)
Dr. Hassan Sibai (Princess Margaret)
8:50 Multiple myeloma
Dr. Keith Stewart (Princess Margaret)
9:10 Mantle cell lymphoma
Dr. Mike Crump (Princess Margaret)
9:30 Management of Cytokine Release Syndrome (CRS): What have we learned?
Dr. Mike Jain (Guest speaker H. Lee Moffitt Cancer Centre)
10:15 Understanding CAR T neurotoxicities (ICANS and beyond)
Dr. Bianca Santomasso (Guest speaker Memorial Sloan Kettering)
11:00 Break
11:15

Small Group Case-Based Breakout Sessions

Small group sessions are fully interactive between faculty and participants. For planning purposes, pre-registration for workshops is required.

  1. CAR T in lymphoma
    Drs. S.Bhella, A.Prica, J. Kuruvilla, I. Gong
  2. CAR T in ALL
    Drs. H.Sibai, R. Sharma, M.Perusini
  3. CAR T in myeloma
    Drs. K.Stewart, A.Devasia
  4. Allied Health and Learners – CAR T-Cell Therapy – Step-By-Step Referral to Infusion
    C.Abreu-Costa, S.Shih, E.Barca
  5. CRS and ICAN – Drs. M. Jain, B., Santomasso, C. Chen
12:30 Lunch break
1:15 Picking the right patient for CAR T
Dr. Anca Prica
1:45 Longterm follow-up post-CAR T: Engaging the community
Dr. Christine Chen
2:15 What’s around the corner in CAR T?
Dr. Sita Bhella (Princess Margaret)
2:45 Closing words
Dr. Christine Chen